Target Pullback Viewed as Buying Opportunity and 4 Stock Analyses Not to Miss
Bristol-Myers Squibb Company (NYSE:BMY): Current price $36.90
Cowen raised their sales and earnings estimates for Bristol-Myers Squibb Company to reflect P&L leverage potential from new drugs including Eliquis. The firm noted that they did not have any estimates in their model for the failed prostate drug, Sprycel, but sees increase in new products. Shares are Outperform rated.
JDS Uniphase Corporation (NASDAQ:JDSU): Current price $15.31
Needham said that JDSU Uniphase Corporation’s analyst day reaffirmed positive industry trends and the company’s improving outlook. The firm raised their price target for shares from $18 to $20 and reiterates a Buy rating on JDSU shares.
Target Corp. (NYSE:TGT): Current price $61.95
Baird will use the pullback in Target Corp. as a good, long-term buying opportunity as they believe that Canada will drive a meaningful acceleration in earnings. The firm expects in-line fourth quarter results and conservative guidance and sees a modest risk to first quarter comps and estimates as comparisons look tough. Shares are Outperform rated with a $70 price target.
Pier 1 Imports Inc. (NYSE:PIR): Current price $22.69
After conducting channel checks, BB&T believes that Pier 1 imports Inc.’s sales trends have remained strong in January and early February. The firm expects the company to report higher than expected fourth quarter earnings per share and they maintain a Buy rating on the stock.
Tower International, Inc. (NYSE:TOWR): Current price $11.57
Baird expects shares of Tower International to increase, following their fourth quarter report. The firm believes their outlook suggests better profitability in 2013, citing a higher backlog and revenue potential. Shares are Outperform rated with a $13 price target.
Don’t Miss: What Will This Apple Fight Lead To?